The accuracy of predicting cardiovascular death based on one compared to several albuminuria values

Kidney International

Volumn 85, Issue 6, 2014, Pages 1421-1428

  Hatlen, Gudrun ^a,b   Romundstad, Solfrid ^a,c,d   Hallan, Stein I ^a,b  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^c Levanger Hospital   (Norway)

^d NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

albuminuria; cardiovascular; cardiovascular events; epidemiology and outcomes; risk factors; survival

Indexed keywords

ALBUMIN; CHOLESTEROL; ALBUMINOID; BIOLOGICAL MARKER; CREATININE;

ADULT; AGE DISTRIBUTION; AGED; ALBUMINURIA; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEART DEATH; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; PREDICTION; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN URINE LEVEL; RANDOMIZED CONTROLLED TRIAL; URINALYSIS; CARDIOVASCULAR DISEASES; COMPARATIVE STUDY; METABOLISM; MIDDLE AGED; MORTALITY; NORWAY; PREDICTIVE VALUE; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR; TIME; URINE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ALBUMINS; ALBUMINURIA; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CREATININE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NORWAY; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; URINALYSIS;

EID: 84901910578     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2013.500     Document Type: Article

References (35)

1. Cerasola G, Cottone S, Mule G. The progressive pathway of microalbuminuria: from early marker of renal damage to strong cardiovascular risk predictor. J Hypertens 2010; 28: 2357-2369.
2. Gerstein HC, Mann JF, Yi Q et al. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 2001; 286: 421-426.
3. Hallan S, Astor B, Romundstad S et al. Association of kidney function and albuminuria with cardiovascular mortality in older vs younger individuals: The HUNT II Study. Arch Intern Med 2007; 167: 2490-2496.
4. Hemmelgarn BR, Manns BJ, Lloyd A et al. Relation between kidney function, proteinuria, and adverse outcomes. JAMA 2010; 303: 423-429.
5. Hillege HL, Fidler V, Diercks GF et al. Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation 2002; 106: 1777-1782.
6. Matsushita K, van der Velde M, Astor BC et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 2010; 375: 2073-2081.
7. Mogensen CE. Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med 1984; 310: 356-360.
8. Romundstad S, Holmen J, Kvenild K et al. Microalbuminuria and all-cause mortality in 2,089 apparently healthy individuals: a 4.4-year follow-up study. The Nord-Trondelag Health Study (HUNT), Norway. Am J Kidney Dis 2003; 42: 466-473.
9. van der Velde M, Matsushita K, Coresh J et al. Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts. Kidney Int 2011; 79(12): 1341-1352.
10. Jensen JS. Intra-individual variation of overnight urinary albumin excretion in clinically healthy middle-aged individuals. Clin Chim Acta 1995; 243: 95-99.
11. Miller WG, Bruns DE, Hortin GL et al. Current issues in measurement and reporting of urinary albumin excretion. Clin Chem 2009; 55: 24-38.
12. Naresh CN, Hayen A, Craig JC et al. Day-to-day variability in spot urine protein-creatinine ratio measurements. Am J Kidney Dis 2012; 60: 561-566.
13. KDOQI. KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease. Am J Kidney Dis 2007; 49: S12-154.
14. Bello A, Thompson S, Lloyd A et al. Multiple versus single and other estimates of baseline proteinuria status as predictors of adverse outcomes in the general population. Am J Kidney Dis 2012; 59: 364-371.
15. Arnlov J, Evans JC, Meigs JB et al. Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study. Circulation 2005; 112: 969-975.
16. Klausen K, Borch-Johnsen K, Feldt-Rasmussen B et al. Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes. Circulation 2004; 110: 32-35.
17. Smink PA, Lambers Heerspink HJ, Gansevoort RT et al. Albuminuria, estimated GFR, traditional risk factors, and incident cardiovascular disease: the PREVEND (Prevention of Renal and Vascular Endstage Disease) Study. Am J Kidney Dis 2012; 60(5): 804-811.
18. Borch-Johnsen K, Feldt-Rasmussen B, Strandgaard S et al. Urinary albumin excretion. An independent predictor of ischemic heart disease. Arterioscler Thromb Vac Biol 1999; 19: 1992-1997.
19. Danziger J. Importance of low-grade albuminuria. Mayo Clin Proc 2008; 83: 806-812.
20. Foley RN, Wang C, Snyder JJ et al. Kidney function and risk triage in adults: threshold values and hierarchical importance. Kidney Int 2011; 79: 99-111.
21. Asselbergs FW, Diercks GF, Hillege HL et al. Effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria. Circulation 2004; 110: 2809-2816.
22. Ibsen H, Olsen MH, Wachtell K et al. Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients: losartan intervention for endpoint reduction in hypertension study. Hypertension 2005; 45: 198-202.
23. Brinkman JW, de Zeeuw D, Duker JJ et al. Falsely low urinary albumin concentrations after prolonged frozen storage of urine samples. Clin Chem 2005; 51: 2181-2183.
24. Brinkman JW, de Zeeuw D, Gansevoort RT et al. Prolonged frozen storage of urine reduces the value of albuminuria for mortality prediction. Clin Chem 2007; 53: 153-154.
25. Schultz CJ, Dalton RN, Turner C et al. Freezing method affects the concentration and variability of urine proteins and the interpretation of data on microalbuminuria. The Oxford Regional Prospective Study Group. Diabet Med 2000; 17: 7-14.
26. Holmen J, Midthjell K, Krü ger Ø et al. The Nord-Tr-ndelag Health Study 1995-97 (HUNT 2): objectives, contents, methods and participation. Norsk Epidemiologi 2003; 13: 19-32.
27. Levey AS, Coresh J, Greene T et al. Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem 2007; 53: 766-772.
28. Statistics Norway O: Central Bureau of Statistics Kongsvinger.
29. Pencina MJ, D'Agostino RB Sr., Larson MG et al. Predicting the 30-year risk of cardiovascular disease: the Framingham heart study. Circulation 2009; 119: 3078-3084.
30. Cook NR. Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation 2007; 115: 928-935.
31. Cook NR. Statistical evaluation of prognostic versus diagnostic models: beyond the ROC curve. Clin Chem 2008; 54: 17-23.
32. Pencina MJ, D'Agostino RB Sr., D'Agostino RB Jr. et al. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 2008; 27: 157-172; discussion 207-112.
33. Tzoulaki I, Liberopoulos G, Ioannidis JP. Use of reclassification for assessment of improved prediction: an empirical evaluation. Int J Epidemiol 2011; 40: 1094-1105.
34. Conroy RM, Pyorala K, Fitzgerald AP et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003; 24: 987-1003.
35. Burnham K, Anderson D. Model Selection and Multimodel Inference: A Practical Information-Theoretic Approach, 2nd edn Springer: New York, USA, 2002.